As of approximately 9:33 AM IST on March 30, 2026 (BSE prices) and 9:34 AM IST (NSE prices), most pharma sector stocks on the BSE and NSE were trading in negative territory. This aligns with broader market weakness, as the Nifty 50 was down around 0.60% and the BSE Sensex declined about 0.95% during early trade.
The data reflects intraday movements at the given timestamps and does not represent closing prices. Pharma stocks, often viewed as defensive, showed widespread declines amid overall market sentiment.
Key Highlights from the Data
- Majority Declines: Out of the listed stocks, the large majority posted negative percentage changes on both BSE and NSE.
- Notable Gainers (early session):
- SUVEN LIFE SCIENCES: +7.88% (BSE at ₹140.25), +7.93% (NSE at ₹140.52)
- WOCKHARDT: +3.27% (BSE at ₹1,227.95), +3.46% (NSE at ₹1,230.60)
- UNICHEM LAB: +2.91% (BSE at ₹292.05), +2.80% (NSE at ₹292.00)
- BLISS GVS PHARMA: +2.53% (BSE at ₹224.65), +3.86% (NSE at ₹226.40)
- CONCORD BIOTECH: +1.30% (BSE at ₹1,027.20), +1.44% (NSE at ₹1,029.40)
- NATCO PHARMA: +1.09% (BSE at ₹988.95), +1.95% (NSE at ₹997.80)
- Smaller gains in stocks like AARTI DRUGS, ACUTAAS CHEMICALS, ALIVUS LIFE SCIENCES, GRANULES INDIA, INNOVA CAPTAB, SANOFI INDIA, SHILPA MEDICARE, and SOLARA ACTIVE PHARMA SCIENCES.
- Notable Losers (early session, selected):
- JUBILANT INDUSTRIES: -4.08% (BSE at ₹1,639.05), -4.46% (NSE at ₹1,633.50)
- SYNGENE INTERNATIONAL: -3.50% (BSE at ₹399.55), -3.68% (NSE at ₹400.30)
- DISHMAN CARBOGEN AMCIS: -3.29% (BSE at ₹138.30), -3.78% (NSE at ₹137.30)
- ANTHEM BIOSCIENCES LTD.: -2.91% (BSE at ₹661.35), -3.13% (NSE at ₹660.10)
- NEULAND LABS: -2.38% (BSE at ₹11,784.50), -2.13% (NSE at ₹11,810.00)
- Gland Pharma: -2.36% (BSE and NSE around ₹1,688)
- YATHARTH HOSPITAL: -3.11% (BSE at ₹622.15)
- Other declines included Alembic Pharma (-2.04%), Aster DM Healthcare (-2.00%), Mankind Pharma (-1.99%), Eris Lifesciences (-1.91%), and several large caps like Divi’s Laboratories (-1.47%), Torrent Pharma (-1.01%), and Sun Pharma (-0.89% BSE / -0.67% NSE).
- Large Cap Examples:
- Sun Pharma: ₹1,779.65 (-0.89% BSE), ₹1,781.50 (-0.67% NSE)
- Dr. Reddy’s Lab: ₹1,266.00 (-1.24% BSE), ₹1,270.10 (-0.91% NSE)
- Cipla: ₹1,227.95 (-1.18% BSE), ₹1,229.20 (-1.05% NSE)
- Lupin: ₹2,316.80 (-0.78% BSE), ₹2,321.60 (-0.57% NSE)
- Divi’s Laboratories: ₹5,908.10 (-1.47% BSE), ₹5,916.50 (-1.35% NSE)
- Zydus Lifesciences: ₹886.80 (-1.09% BSE), ₹888.35 (-0.93% NSE)
- Other Notes: Abbott India traded mixed with minor declines. Some stocks like Caplin Point and Piramal Pharma had limited or no NSE listing in the provided data. Wyeth showed unusual figures on NSE, likely due to data anomaly or specific corporate event.
Broader Market Context
On March 30, 2026, early trading reflected continued pressure on Indian equities following recent sessions marked by geopolitical concerns, including US-Iran tensions and elevated crude oil prices. The Nifty Pharma index had shown mixed performance in prior days (e.g., down 0.50% on March 27 close around 22,565 levels), consistent with the intraday trend observed here.
Stock prices fluctuate throughout the trading day; investors should verify latest values from official exchanges (BSE/NSE) or reliable platforms.